Alswat Amal S
Department of Biotechnology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Life (Basel). 2024 Oct 9;14(10):1279. doi: 10.3390/life14101279.
The human gut microbiota is a complex ecosystem harboring thousands of microbial strains that play a crucial role in maintaining the overall well-being of its host. The composition of the gut microbiota varies with age from infancy to adulthood and is influenced by dietary habits, environment, and genetic disposition. Recent advances in culture-independent techniques and nucleic acid sequencing have improved our understanding of the diversity of the gut microbiota. The microbial species present in the gut release short-chain fatty acids (SCFAs), which have anti-inflammatory properties. The gut microbiota also plays a substantial role in modulating the host's immune system, promoting immune tolerance, and maintaining homeostasis. The impact of the gut microbiota on the health of the host is quite evident, as gut dysbiosis has been linked to various diseases, including metabolic disorders, autoimmune diseases, allergies, and inflammatory bowel diseases. The gut microbiota has bidirectional communication with the respiratory system, creating the gut-lung axis, which has been associated with different respiratory diseases. Therapeutic approaches targeting the gut microbiota, such as probiotics, prebiotics, dietary interventions, and fecal microbiota transplantation (FMT), aim to restore microbial balance and promote the growth of beneficial strains in the gut. Nonetheless, gaining knowledge of the complex interactions between the gut microbiota and the host is necessary to develop personalized medicine approaches and microbiota-based therapies for various conditions. This review summarizes studies related to the gut-lung axis with particular emphasis on the role of the microbiota. Future research directions are also discussed.
人类肠道微生物群是一个复杂的生态系统,包含数千种微生物菌株,这些菌株在维持宿主的整体健康方面发挥着关键作用。从婴儿期到成年期,肠道微生物群的组成会随着年龄的变化而变化,并受到饮食习惯、环境和遗传倾向的影响。非培养技术和核酸测序的最新进展增进了我们对肠道微生物群多样性的理解。肠道中存在的微生物物种会释放具有抗炎特性的短链脂肪酸(SCFAs)。肠道微生物群在调节宿主免疫系统、促进免疫耐受和维持体内平衡方面也发挥着重要作用。肠道微生物群对宿主健康的影响十分明显,因为肠道微生物失调与各种疾病有关,包括代谢紊乱、自身免疫性疾病、过敏和炎症性肠病。肠道微生物群与呼吸系统存在双向交流,形成了肠 - 肺轴,这与不同的呼吸系统疾病有关。针对肠道微生物群的治疗方法,如益生菌、益生元、饮食干预和粪便微生物群移植(FMT),旨在恢复微生物平衡并促进肠道中有益菌株的生长。尽管如此,要开发针对各种病症的个性化医疗方法和基于微生物群的疗法,了解肠道微生物群与宿主之间的复杂相互作用是必要的。本综述总结了与肠 - 肺轴相关的研究,特别强调了微生物群的作用。还讨论了未来的研究方向。